Summary: In a secondary analysis of the LIFE-Moms prenatal lifestyle trial, maternal metabolic phenotype, not just gestational weight gain, drove outcomes: metabolically unhealthy obesity carried far more gestational diabetes and higher infant adiposity, and the two phenotypes responded similarly to the behavioural intervention.
PICO Summary
| Element | Detail |
|---|---|
| Population | 640 pregnant individuals with obesity in the LIFE-Moms trials, classified as metabolically healthy (MHO, n=228) or unhealthy (MUO, n=172). |
| Intervention | Prenatal intensive behavioural therapy (diet and physical activity) to meet gestational weight-gain guidelines. |
| Comparison | Outcomes and treatment response compared between MHO and MUO phenotypes. |
| Outcome | The phenotypes did not differ in response to treatment. MUO had lower weekly gestational weight gain (0.30 vs 0.41 kg/wk) and fewer exceeding guidelines, but a higher incidence of gestational diabetes (23.8% vs 9.8%) and infants with higher adiposity (12.5% vs 11.7% fat). |
Expert Commentary
This is a well-conceived secondary analysis with an important conceptual message: in pregnancy, the metabolic quality of obesity matters more than the number on the scale or the weight gained. Women with metabolically unhealthy obesity had markedly more gestational diabetes and infants with greater adiposity, despite gaining less weight, which neatly illustrates why a singular focus on gestational weight gain has produced such modest trial results. I want to correct one nuance in the earlier framing, though: the analysis found that the two phenotypes did not differ in their response to the behavioural intervention, so it is not that unhealthy obesity was more treatable, rather that phenotype shaped outcomes largely independently of how much the intervention moved weight. As a preplanned subgroup analysis of a completed trial, it is hypothesis-strengthening rather than definitive, and MHO/MUO definitions vary. Can I use this with my patients? Yes, conceptually. It supports assessing metabolic health early in pregnancy in women with obesity, with earlier glucose evaluation and closer monitoring for the metabolically unhealthy, and tempering expectations that weight-gain counselling alone will fix metabolic risk. Interventions targeting the metabolic milieu itself, early, are the logical next step.
References
Flanagan EW, Drews KL, Cade WT, et al. Metabolic health and heterogenous outcomes of prenatal interventions: a secondary analysis of a randomized clinical trial. JAMA Netw Open. 2025;8(8):e2528264. doi:10.1001/jamanetworkopen.2025.28264